Skip to content

An Independent Reference on Medical Travel Abroad · Reader-Funded

Est. 2026 · 19 countries · 112 factors Sign in

Map
Countries
Clinics
Specialties
Rankings
Compare
Methodology

Subscribe

Search the index

The Index

Map Home
Countries 19
Clinics
Specialties 8 · 112 factors
Rankings
Compare

Method & Editorial

Methodology
The Scale
Read a sample report

Sign in Subscribe

The Index
Sources
Access Barriers to Pembrolizumab in Brazil

The Archive · A Source

Access Barriers to Pembrolizumab in Brazil

JAMA Network Open 2025 pmc.ncbi.nlm.nih.gov/articles/PMC12374216

Reports that cite this source

Brazil

Chemotherapy & Immunotherapy Quality in Brazil
Medication Availability in Brazil

← Back to the sources archive

An independent reference on the private medical services available to foreigners — 19 countries assessed across 112 factors, one cited report at a time. Independent and reader-funded: no provider pays to influence a finding.

The Index

The Map
Countries
Clinics
Specialties
Rankings
Compare

Method & Editorial

Methodology
The published scale
Editorial standards
Read a sample report
Insights

The Publication

About & independence
Pricing
FAQ
Glossary
Help
Contact the editors

Medical disclaimer

Epidaurus publishes comparative research to inform decisions; it is not medical advice and is no substitute for consultation with a qualified clinician. Findings are assessed by our editorial pipeline against a published scale from dated public sources, and may not reflect an individual provider's current standard of care. Verify accreditation, legality, and clinical suitability for your own case before acting on anything you read here. Read the full disclaimer.

Every score is set against the published scale and carries its citations — the verdict is free; the evidence is the report.

© 2026 Epidaurus · Set in Newsreader, Hanken Grotesk & IBM Plex Mono

Terms · Privacy · Refunds · Cookies · Imprint · Accessibility · Sitemap